Iridex (IRIX) Net Margin Growth (1y) (2011 - 2026)

Iridex (IRIX) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -314.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 123.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 94.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1,132.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 656.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 201.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -430.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Iridex 15.93 Mn 11.33 Mn 4.74 Mn 973.00

Historic Data

Download Data
DateValue
Apr 4, 2026 973.00
Jan 3, 2026 530.00
Sep 27, 2025 409.00
Jun 28, 2025 1,389.00
Mar 29, 2025 1,528.00
Dec 28, 2024 -6,043.00
Sep 28, 2024 -304.00
Jun 29, 2024 31.00
Mar 30, 2024 -1,420.00
Dec 30, 2023 1,179.00
Sep 30, 2023 -158.00
Jul 1, 2023 -522.00
Apr 1, 2023 261.00
Dec 31, 2022 3,900.00
Oct 1, 2022 425.00
Jul 2, 2022 -2,667.00
Apr 2, 2022 -105.00
Oct 2, 2021 321.00
Jul 3, 2021 5,508.00
Apr 3, 2021 149.00